Mettler-Toledo International (NYSE:MTD) Research Coverage Started at Barclays

Barclays began coverage on shares of Mettler-Toledo International (NYSE:MTD) in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The brokerage issued an overweight rating and a $1,325.00 price target on the medical instruments supplier’s stock.

A number of other brokerages have also issued reports on MTD. Wall Street Zen lowered Mettler-Toledo International from a “buy” rating to a “hold” rating in a research report on Monday, May 5th. Wells Fargo & Company upped their price objective on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an “equal weight” rating in a research report on Monday, May 5th. Citigroup raised Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,400.00 price objective on the stock in a research report on Monday, April 7th. Robert W. Baird cut their price objective on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 22nd. Finally, Jefferies Financial Group raised Mettler-Toledo International from an “underperform” rating to a “hold” rating and cut their price objective for the stock from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. Eight equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $1,300.36.

Mettler-Toledo International Stock Up 0.3%

Shares of NYSE MTD opened at $1,196.81 on Tuesday. The firm has a market cap of $24.87 billion, a price-to-earnings ratio of 29.85, a PEG ratio of 3.53 and a beta of 1.38. Mettler-Toledo International has a 52-week low of $946.69 and a 52-week high of $1,546.93. The business’s 50 day moving average is $1,130.39 and its two-hundred day moving average is $1,198.86.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.90 by $0.29. The company had revenue of $883.74 million for the quarter, compared to analyst estimates of $876.61 million. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The firm’s quarterly revenue was down 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $8.89 earnings per share. Analysts anticipate that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other news, Director Michael A. Kelly sold 1,062 shares of the company’s stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the sale, the director now owns 120 shares in the company, valued at approximately $139,191.60. This represents a 89.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.94% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Mettler-Toledo International

Several large investors have recently made changes to their positions in MTD. GAMMA Investing LLC boosted its holdings in shares of Mettler-Toledo International by 131,246.3% in the first quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier’s stock valued at $456,018,000 after acquiring an additional 385,864 shares in the last quarter. Norges Bank bought a new position in shares of Mettler-Toledo International in the fourth quarter valued at approximately $372,954,000. Proficio Capital Partners LLC bought a new position in shares of Mettler-Toledo International in the fourth quarter valued at approximately $163,216,000. Alliancebernstein L.P. boosted its holdings in shares of Mettler-Toledo International by 21.6% in the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock valued at $837,653,000 after acquiring an additional 126,147 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. boosted its holdings in shares of Mettler-Toledo International by 36.1% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 363,107 shares of the medical instruments supplier’s stock valued at $444,327,000 after acquiring an additional 96,300 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.